Shukra Pharmaceuticals Partners with APITCO to Expand Role in Government Healthcare Projects

Strategic Collaboration Announced

Shukra Pharmaceuticals Ltd has entered into a formal service agreement with APITCO Limited, a public sector undertaking, to jointly execute healthcare-related government assignments. The partnership aims to leverage Shukra’s manufacturing expertise and APITCO’s institutional reach to deliver high-impact public health solutions.

Key Highlights

• The agreement covers formulation development, supply chain support, and regulatory compliance for government healthcare programs

• Shukra will manufacture essential medicines and therapeutic products under WHO-GMP standards

• APITCO will facilitate project coordination, tender participation, and stakeholder engagement

Operational Significance

• The collaboration is expected to enhance Shukra’s visibility in public sector tenders and expand its institutional client base

• It aligns with the company’s recent expansion into Mumbai, Gurgaon, Bangalore, and Kolkata to tap regional markets

• The move supports Shukra’s long-term goal of becoming a preferred partner for government and semi-government healthcare initiatives

Sources: Rediff MoneyWiz, Business Upturn, Moneycontrol